Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Kalra

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 24, 2023
Who Modifies the Modifiers: A High-Resolution View of the Genetic Modifiers of Cystic FibrosisSean Kalra, Michael H Cho
Chest|July 10, 2025
ResponseSean Kalra, Michael H Cho, Matthew Moll
Frontiers in Allergy|October 17, 2025
Machine learning-derived genetic risk scores identify IL21 as a predictor of response to omalizumab and dupilumab in asthmaAyobami Akenroye, Chengyue Zhang, Tanawin Nopsopon, et al.
Oncogene|April 21, 2015
Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitorsSarah M Haeger, Joshua J Thompson, Sean Kalra, et al.
Chest|February 13, 2025
The Association of Interstitial Lung Abnormalities and Preserved Ratio Impaired Spirometry With MortalitySean Kalra, Brian Hobbs, Gary M Hunninghake, et al.
American Journal of Respiratory and Critical Care Medicine|August 12, 2024
Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGeneJonathan A Rose, Ann-Marcia C Tukpah, Claire Cutting, et al.
The European Respiratory Journal|July 3, 2025
Interstitial Lung Abnormalities, Coronary Heart Disease, and MortalityClaire C Cutting, Jonathan A Rose, Ann-Marcia C Tukpah, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Multi-Trait Polygenic Scores for COPD and COPD Exacerbations Implicate Druggable ProteinsChengyue Zhang, Iain R Konigsberg, Yixuan He, et al.
JCI Insight|February 19, 2026
Multi-trait polygenic scores for COPD and COPD exacerbations implicate druggable proteinsChengyue Zhang, Iain R Konigsberg, Yixuan He, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
American Journal of Respiratory and Critical Care Medicine|March 24, 2023
Who Modifies the Modifiers: A High-Resolution View of the Genetic Modifiers of Cystic FibrosisSean Kalra, Michael H Cho
Chest|July 10, 2025
ResponseSean Kalra, Michael H Cho, Matthew Moll
Frontiers in Allergy|October 17, 2025
Machine learning-derived genetic risk scores identify IL21 as a predictor of response to omalizumab and dupilumab in asthmaAyobami Akenroye, Chengyue Zhang, Tanawin Nopsopon, et al.
Oncogene|April 21, 2015
Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitorsSarah M Haeger, Joshua J Thompson, Sean Kalra, et al.
Chest|February 13, 2025
The Association of Interstitial Lung Abnormalities and Preserved Ratio Impaired Spirometry With MortalitySean Kalra, Brian Hobbs, Gary M Hunninghake, et al.
American Journal of Respiratory and Critical Care Medicine|August 12, 2024
Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGeneJonathan A Rose, Ann-Marcia C Tukpah, Claire Cutting, et al.
The European Respiratory Journal|July 3, 2025
Interstitial Lung Abnormalities, Coronary Heart Disease, and MortalityClaire C Cutting, Jonathan A Rose, Ann-Marcia C Tukpah, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Multi-Trait Polygenic Scores for COPD and COPD Exacerbations Implicate Druggable ProteinsChengyue Zhang, Iain R Konigsberg, Yixuan He, et al.
JCI Insight|February 19, 2026
Multi-trait polygenic scores for COPD and COPD exacerbations implicate druggable proteinsChengyue Zhang, Iain R Konigsberg, Yixuan He, et al.
Pageof 1